In Silico Approaches to Deliver Better Antibodies by Design: The Past, the Present and the Future
The recognition of the importance of drug-like properties beyond potency to reduce clinical attrition of biologics has driven significant progress in the development of in vitro and in silico tools for developability assessment of antibody sequences. It is now routine to identify and eliminate or optimize antibody hits with poor developability profiles. To further accelerate discovery timelines and reduce clinical and non-clinical development attrition rates, more proactive in silico approaches to design sequence spaces with favorable developability profiles are required. From pragmatically front-loading structure based drug design for developability, to combining next generation sequencing with machine learning to shape screening libraries, to adapting the use of artificial intelligence and deep learning for immunoglobulins, we review herein progressively more proactive approaches to developability by design.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DesignSimilar Papers 제목 키워드 기반
AntiBARTy Diffusion for Property Guided Antibody Design
Over the past decade, antibodies have steadily grown in therapeutic importance thanks to their high specificity and low risk of adverse effects compared to other drug modalities. While traditional antibody discovery is p…
DiversityLanguage ModelingLanguage ModellingSpecificityAntBO: Towards Real-World Automated Antibody Design with Combinatorial Bayesian Optimisation
Antibodies are canonically Y-shaped multimeric proteins capable of highly specific molecular recognition. The CDRH3 region located at the tip of variable chains of an antibody dominates antigen-binding specificity. There…
Bayesian OptimisationBenchmarkingSpecificityApplying computational protein design to therapeutic antibody discovery -- current state and perspectives
Machine learning applications in protein sciences have ushered in a new era for designing molecules in silico. Antibodies, which currently form the largest group of biologics in clinical use, stand to benefit greatly fro…
Drug DiscoveryProtein DesignBayesian Optimization of Antibodies Informed by a Generative Model of Evolving Sequences
To build effective therapeutics, biologists iteratively mutate antibody sequences to improve binding and stability. Proposed mutations can be informed by previous measurements or by learning from large antibody databases…
Bayesian OptimizationLanguage ModelingLanguage ModellingLarge Language ModelAbDiffuser: Full-Atom Generation of in vitro Functioning Antibodies
We introduce AbDiffuser, an equivariant and physics-informed diffusion model for the joint generation of antibody 3D structures and sequences. AbDiffuser is built on top of a new representation of protein structure, reli…
Denoising